Breast Cancer Core Needle Biopsy Market Study Analysis with Forecast to 2031

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Breast Cancer Core Needle Biopsy Market - (By Technology (MRI-based Breast Biopsy, Ultrasound-based Breast Biopsy, Mammography-based (Stereotactic) Breast Biopsy, CT-based Breast Biopsy, Other Image Based Breast Biopsy), By End-use (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Breast Cancer Core Needle Biopsy Market Size is valued at USD 697.3 Mn in 2023 and is predicted to reach USD 1,042.3 Mn by the year 2031 at a 5.34% CAGR during the forecast period for 2024-2031.

Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/2310

Core needle biopsy offers several advantages over traditional surgical methods, including minimal invasiveness, shorter recovery times, and greater cost-efficiency. As global awareness of the importance of early disease detection increases, the demand for core needle biopsy procedures is expected to rise, particularly due to their essential role in identifying conditions at an early stage and improving patient outcomes. This procedure involves the surgical removal of tissue or fluid samples for microscopic examination to detect the presence of malignant cells.

The market is further supported by technological advancements and innovations in breast biopsy devices. However, factors such as the high cost of breast biopsy procedures and potential side effects may restrain market growth. Additionally, the growing incidence of breast cancer highlights the need for increased promotional efforts by vendors.

List of Prominent Players in the Breast Cancer Core Needle Biopsy Market:
• Intact Medical Corporation
• Ethicon Surgical Technologies.
• Galling SRL
• Leica Biosystems Nussle GmbH
• Hologic, Inc
• Argon Medical Devices
• Encapsule Medical Devices LLC.
• Cook Medical Incorporated
• Becton Dickinson and Company
• C.R. Bard, Inc.
• Zenalux Biomedical, Inc.,
• F. Hoffmann-La Roche Ltd.,
• OncoCyte Corporation,
• Laboratory Corporation of America Holdings (LabCorp),
• Scion Medical Technologies,
• Planmed Oy,
• Aurora Imaging Technology Inc.,
• Carestream Health,
• Cardinal Health,
• PerkinElmer
• QIAGEN
• Thermo Fisher Scientific
• Medtronic
• Danaher Corporation
• Others

Market Dynamics:
Drivers-
The breast biopsy instrument market is experiencing significant growth, primarily driven by the rising incidence of breast cancer and continuous advancements in imaging and biopsy technologies. Technological innovations in biopsy instruments are enhancing procedural efficiency and diagnostic accuracy, further contributing to market expansion. However, the high cost associated with breast biopsy procedures and their potential side effects may hinder wider adoption.

Curious About This Latest Version Of The Report? Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/2310

Challenges:
Core needle biopsy procedures face certain limitations, including the potential for sampling errors and inconclusive results. Tumor size and location can affect diagnostic accuracy, sometimes leading to false negatives or uncertain outcomes. Patient discomfort and anxiety associated with the procedure also pose barriers, potentially deterring individuals from undergoing necessary diagnostic evaluations.

Regional Trends:
North America is anticipated to maintain a dominant position in the breast cancer core needle biopsy market, with the United States and Canada accounting for a substantial share of regional revenue. The growth of medical tourism in the region further strengthens market value. In the Asia-Pacific region, rapidly developing economies are making significant investments in healthcare infrastructure, supporting market expansion. Increased awareness of breast biopsy procedures in emerging markets is boosting demand. Moreover, advancements in medical technologies in countries like China, India, and South Korea are prompting healthcare institutions to invest in cutting-edge diagnostic tools such as vacuum-assisted biopsy systems and liquid biopsy techniques, accelerating regional market growth.

Recent Developments:
• In Jan 2021, Somatex Medical Technologies GmbH, a market leader in biopsy site markers and localization technologies, was acquired by Hologic, Inc. for an estimated $64 million, the company disclosed this morning. Hologic's approach to offering an all-encompassing collection of groundbreaking solutions spanning the entire spectrum of breast health care was reinforced by the transaction.

Get Specific Chapter/Information From The Report: @
https://www.insightaceanalytic.com/customisation/2310

Segmentation of Breast Cancer Core Needle Biopsy Market-
By Technology
• MRI-based Breast Biopsy
• Ultrasound-based Breast Biopsy
• Mammography-based (Stereotactic) Breast Biopsy
• CT-based Breast Biopsy
• Other Image Based Breast Biopsy
By End-use
• Hospitals & Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes"
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Get More Information :
https://www.insightaceanalytic.com/report/breast-cancer-core-needle-biopsy-market/2310

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG

Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace

This release was published on openPR.